pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 6,918 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
  • Preclinical
    Oximo
    Genital Herpes Oxymo Technologies Inc
  • Preclinical
    Oxy-133
    Osteoporosis Max Biopharma Inc
  • Preclinical
    Oxy-210
    Metabolic Dysfunction-Associated Steatohepatitis (MASH or… Max Biopharma Inc
  • Phase 1
← prev
page 119 of 231
next →
131
Pain89
Neurology1
P-01
Pancreatic Cancer
Hangzhou Neoantigen Therapeutics Co Ltd
  • Preclinical
    P-1155
    Chronic Obstructive Pulmonary Disease (COPD) Parion Sciences Inc
  • Phase 2
    P-12
    Burns NeoMatrix Therapeutics Inc
  • Phase 2
    P-4M01
    Periodontal Disease P4 Microbiome Inc
  • Preclinical
    P-8
    Alzheimer's Disease Cenna Biosciences Inc
  • Preclinical
    P-BCMACD19-ALLO1
    Autoimmune Disorders Poseida Therapeutics Inc
  • Preclinical
    P-MAPA
    Schistosomiasis Farmabrasilis
  • Preclinical
    P5P Analogues
    Unspecified$MCUJF MEDICURE INC
  • Phase 1
    PA-001
    Coronavirus Disease 2019 (COVID-19) PeptiAID Inc
  • Phase 2
    PALI-2108
    Ulcerative Colitis$PALI PALISADE BIO, INC.
  • PANTOPRAZOLE SODIUM DELAYED-RELEASE
    PANTOPRAZOLE SODIUM DELAYED-RELEASE
    no indication MANKIND PHARMA
  • PAROXETINE
    PAROXETINE
    no indication LEGACY PHARMA
  • Phase 1
    PAS-004
    Plexiform Neurofibroma$KTTA Pasithea Therapeutics Corp.
  • Preclinical
    PAX-001
    Tendon and Ligament Pain PAX Therapeutics Inc
  • Phase 2
    PAX-1
    Bile Duct Cancer (Cholangiocarcinoma) Komipharm International Co Ltd
  • Phase 3
    PAX-101
    suramin hexasodium
    African Trypanosomiasis Kuvatris Therapeutics Inc
  • PAZOPANIB
    PAZOPANIB
    no indication EUGIA PHARMA
  • Preclinical
    PB-207
    Rheumatoid Arthritis Pan-Biome Pharmaceuticals Inc
  • phase_0
    PBA-0111
    Alveolar Soft Part Sarcoma (ASPS) Pure Biologics SA
  • phase_0
    PBA-0405
    Alveolar Soft Part Sarcoma (ASPS) Pure Biologics SA
  • Preclinical
    PBAS-499
    Phenylketonuria (PKU) Pluvia AS
  • Phase 1
    PBCAR-19B
    Diffuse Large B-Cell Lymphoma$DTIL PRECISION BIOSCIENCES INC
  • Phase 2
    PBF-999
    Prader-Willi Syndrome (PWS) Palobiofarma SL
  • Phase 2
    PBFT-02
    Frontotemporal Dementia (Pick Disease)$PASG Passage BIO, Inc.
  • Phase 2
    PBGENE-HBV
    Hepatitis B$DTIL PRECISION BIOSCIENCES INC
  • Phase 2
    PBGM-01
    GM1 Gangliosidosis (Beta Galactosidase 1 Deficiency) GEMMA Biotherapeutics Inc
  • Phase 2
    PBI-05204
    Metastatic Adenocarcinoma of The Pancreas Phoenix Biotechnology Inc